查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1901633

計算生物學市場－全球產業規模、佔有率、趨勢、機會和預測，按應用、工具、服務、最終用戶、地區和競爭格局分類，2021-2031年預測

Computational Biology Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Application, By Tool, By Service, By End User, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球計算生物學市場規模將從2025年的57.4億美元成長到2031年的91.3億美元，複合年成長率為8.04%。計算生物學是一個關鍵領域，它利用演算法、數學模型和統計技術來分析和解釋複雜的生物資料。

市場概覽
預測期 2027-2031
市場規模：2025年 57.4億美元
市場規模：2031年 91.3億美元
複合年成長率：2026-2031年 8.04%
成長最快的細分市場 工業和商業
最大的市場 北美洲

主要市場促進因素

人工智慧和機器學習的融合正在從根本上重塑全球計算生物學市場，加速識別可行的候選療法。先進的演算法和生成模型如今能夠以前所未有的速度預測蛋白質結構並最佳化分子設計，從而顯著減少臨床前研究所需的時間和資金。

主要市場挑戰

資料隱私和安全問題是全球計算生物學市場擴張的一大障礙。該領域從根本上依賴對包含敏感基因組和臨床資訊的大量資料集進行聚合和分析，因此患者隱私至關重要。

主要市場趨勢

數位孿生技術在電腦模擬臨床試驗中的應用，透過創建虛擬患者模型來模擬生物反應，正在革新藥物研發的驗證階段。這種方法解決了傳統隨機對照試驗效率低下的難題，它允許研究人員產生合成對照組，從而減少了安慰劑組所需的大量人體受試者招募工作。

目錄

第1章：產品概述

第2章：研究方法

第3章：執行概要

第4章：顧客之聲

第5章：全球計算生物學市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按應用領域（細胞和生物模擬、藥物發現和疾病建模、臨床前藥物開發、臨床試驗、人體模擬軟體）
    • 依工具分類（資料庫、基礎設施（硬體）、分析軟體和服務）
    • 依服務類型（內部服務、合約服務）
    • 按最終用戶（學術界、工業界和商業界）分類
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美計算生物學市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲計算生物學市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區計算生物學市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲計算生物學市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲計算生物學市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章：市場動態

  • 促進要素
  • 挑戰

第12章：市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章：全球計算生物學市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商議價能力
  • 顧客的力量
  • 替代產品的威脅

第15章：競爭格局

  • Dassault Systemes SE
  • Certara Inc
  • Chemical Computing Group ULC
  • Compugen Ltd
  • Rosa & Co. LLC
  • GeneData AG
  • Insilico Biotechnology AG
  • Instem PLC
  • Strand Life Sciences Pvt Ltd
  • Schrodinger Inc

第16章：策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 16136

The Global Computational Biology Market will grow from USD 5.74 Billion in 2025 to USD 9.13 Billion by 2031 at a 8.04% CAGR. Computational biology serves as a pivotal field that utilizes algorithms, mathematical models, and statistical techniques to analyze and interpret complex biological data.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 5.74 Billion
Market Size 2031USD 9.13 Billion
CAGR 2026-20318.04%
Fastest Growing SegmentIndustry and Commercials
Largest MarketNorth America

Key Market Drivers

Integration of Artificial Intelligence and Machine Learning is fundamentally reshaping the Global Computational Biology Market by expediting the identification of viable therapeutic candidates. Advanced algorithms and generative models can now predict protein structures and optimize molecular designs with unprecedented speed, significantly reducing the time and capital required for preclinical research. This transformative potential has triggered substantial industrial consolidation and capital flow into AI-driven biotech firms.

Key Market Challenges

Data privacy and security concerns constitute a formidable barrier to the expansion of the global computational biology market. This field relies fundamentally on the aggregation and analysis of massive datasets containing sensitive genomic and clinical information, making patient confidentiality paramount. The risk of unauthorized access compels research institutions and pharmaceutical companies to implement restrictive data governance policies. These rigid protocols often result in data silos where valuable biological information remains isolated within a single organization rather than being shared across collaborative research networks.

Key Market Trends

Adoption of Digital Twins for In Silico Clinical Trials is revolutionizing the validation phase of pharmaceutical development by creating virtual patient models to simulate biological responses. This approach addresses the inefficiency of traditional randomized control trials by allowing researchers to generate synthetic control arms, thereby reducing the need for recruiting large numbers of human participants for placebo groups.

Key Market Players

  • Dassault Systemes SE
  • Certara Inc
  • Chemical Computing Group ULC
  • Compugen Ltd
  • Rosa & Co. LLC
  • GeneData AG
  • Insilico Biotechnology AG
  • Instem PLC
  • Strand Life Sciences Pvt Ltd
  • Schrodinger Inc

Report Scope:

In this report, the Global Computational Biology Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Computational Biology Market, By Application:

  • Cellular and Biological Simulation
  • Drug Discovery and Disease Modelling
  • Preclinical Drug Development
  • Clinical Trials
  • Human Body Simulation Software

Computational Biology Market, By Tool:

  • Databases
  • Infrastructure (Hardware)
  • Analysis Software and Services

Computational Biology Market, By Service:

  • In-house
  • Contract

Computational Biology Market, By End User:

  • Academics
  • Industry and Commercials

Computational Biology Market, By Region:

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Computational Biology Market.

Available Customizations:

Global Computational Biology Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Computational Biology Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Application (Cellular and Biological Simulation, Drug Discovery and Disease Modelling, Preclinical Drug Development, Clinical Trials, Human Body Simulation Software)
    • 5.2.2. By Tool (Databases, Infrastructure (Hardware), Analysis Software and Services)
    • 5.2.3. By Service (In-house, Contract)
    • 5.2.4. By End User (Academics, Industry and Commercials)
    • 5.2.5. By Region
    • 5.2.6. By Company (2025)
  • 5.3. Market Map

6. North America Computational Biology Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Application
    • 6.2.2. By Tool
    • 6.2.3. By Service
    • 6.2.4. By End User
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Computational Biology Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Application
        • 6.3.1.2.2. By Tool
        • 6.3.1.2.3. By Service
        • 6.3.1.2.4. By End User
    • 6.3.2. Canada Computational Biology Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Application
        • 6.3.2.2.2. By Tool
        • 6.3.2.2.3. By Service
        • 6.3.2.2.4. By End User
    • 6.3.3. Mexico Computational Biology Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Application
        • 6.3.3.2.2. By Tool
        • 6.3.3.2.3. By Service
        • 6.3.3.2.4. By End User

7. Europe Computational Biology Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Application
    • 7.2.2. By Tool
    • 7.2.3. By Service
    • 7.2.4. By End User
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Computational Biology Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Application
        • 7.3.1.2.2. By Tool
        • 7.3.1.2.3. By Service
        • 7.3.1.2.4. By End User
    • 7.3.2. France Computational Biology Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Application
        • 7.3.2.2.2. By Tool
        • 7.3.2.2.3. By Service
        • 7.3.2.2.4. By End User
    • 7.3.3. United Kingdom Computational Biology Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Application
        • 7.3.3.2.2. By Tool
        • 7.3.3.2.3. By Service
        • 7.3.3.2.4. By End User
    • 7.3.4. Italy Computational Biology Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Application
        • 7.3.4.2.2. By Tool
        • 7.3.4.2.3. By Service
        • 7.3.4.2.4. By End User
    • 7.3.5. Spain Computational Biology Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Application
        • 7.3.5.2.2. By Tool
        • 7.3.5.2.3. By Service
        • 7.3.5.2.4. By End User

8. Asia Pacific Computational Biology Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Application
    • 8.2.2. By Tool
    • 8.2.3. By Service
    • 8.2.4. By End User
    • 8.2.5. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Computational Biology Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Application
        • 8.3.1.2.2. By Tool
        • 8.3.1.2.3. By Service
        • 8.3.1.2.4. By End User
    • 8.3.2. India Computational Biology Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Application
        • 8.3.2.2.2. By Tool
        • 8.3.2.2.3. By Service
        • 8.3.2.2.4. By End User
    • 8.3.3. Japan Computational Biology Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Application
        • 8.3.3.2.2. By Tool
        • 8.3.3.2.3. By Service
        • 8.3.3.2.4. By End User
    • 8.3.4. South Korea Computational Biology Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Application
        • 8.3.4.2.2. By Tool
        • 8.3.4.2.3. By Service
        • 8.3.4.2.4. By End User
    • 8.3.5. Australia Computational Biology Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Application
        • 8.3.5.2.2. By Tool
        • 8.3.5.2.3. By Service
        • 8.3.5.2.4. By End User

9. Middle East & Africa Computational Biology Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Application
    • 9.2.2. By Tool
    • 9.2.3. By Service
    • 9.2.4. By End User
    • 9.2.5. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Computational Biology Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Application
        • 9.3.1.2.2. By Tool
        • 9.3.1.2.3. By Service
        • 9.3.1.2.4. By End User
    • 9.3.2. UAE Computational Biology Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Application
        • 9.3.2.2.2. By Tool
        • 9.3.2.2.3. By Service
        • 9.3.2.2.4. By End User
    • 9.3.3. South Africa Computational Biology Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Application
        • 9.3.3.2.2. By Tool
        • 9.3.3.2.3. By Service
        • 9.3.3.2.4. By End User

10. South America Computational Biology Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Application
    • 10.2.2. By Tool
    • 10.2.3. By Service
    • 10.2.4. By End User
    • 10.2.5. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Computational Biology Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Application
        • 10.3.1.2.2. By Tool
        • 10.3.1.2.3. By Service
        • 10.3.1.2.4. By End User
    • 10.3.2. Colombia Computational Biology Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Application
        • 10.3.2.2.2. By Tool
        • 10.3.2.2.3. By Service
        • 10.3.2.2.4. By End User
    • 10.3.3. Argentina Computational Biology Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Application
        • 10.3.3.2.2. By Tool
        • 10.3.3.2.3. By Service
        • 10.3.3.2.4. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Computational Biology Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Dassault Systemes SE
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Certara Inc
  • 15.3. Chemical Computing Group ULC
  • 15.4. Compugen Ltd
  • 15.5. Rosa & Co. LLC
  • 15.6. GeneData AG
  • 15.7. Insilico Biotechnology AG
  • 15.8. Instem PLC
  • 15.9. Strand Life Sciences Pvt Ltd
  • 15.10. Schrodinger Inc

16. Strategic Recommendations

17. About Us & Disclaimer